Skip to content

Investigation of the effects on gait and locomotion of people with unstable ankles

Effects of ankle malalignment on gait characteristics and locomotor mechanisms - Effects on gait and locomotion in ankle malalignment

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000043079
Enrollment
59
Registered
2021-01-21
Start date
2020-04-19
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ankle joint misalignment

Interventions

Patients with ankle malalignment were asked to walk 5 m without adjustment, and after walking, they were asked to make heel contact, and ankle joint dorsiflexion, stride length, and 5 m walking time w

Sponsors

True Treat Group INC.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Persons with ankle joint malalignment

Exclusion criteria

Exclusion criteria: Gender, height and weight differences, and other underlying diseases will not be taken into account, and the focus will be on ankle malalignment. We will ethically exclude cases where there is a compliance problem, where the purpose of the study is explained to the subjects and they fully understand the study, but there are subjects who do not understand the study, or who are judged to be unsuitable for the study due to their physical condition.

Design outcomes

Primary

MeasureTime frame
The effective area at the time of ground contact during walking in the truss mechanism and windlass mechanism, ankle joint dorsiflexion, walking speed, and stride length during a 5 m walk of a person with ankle malalignment are measured and evaluated before and after ankle alignment adjustment, respectively. The evaluation and measurement days will be conducted during one day each. The period until the end of the test shall be one month.

Countries

Japan

Contacts

Public ContactNoriomi Tsunoda

TrueTreatGroup Inc. Representative Director

aoisekkotsuin@hotmail.co.jp0362643372

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026